🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to investigate the efficacy and safety of long...
Status
Completed
Location
Kameda Medical Center
Start Date
2018-02-18
Trial ID
NCT03416374
Treatments Being Tested
This is a Phase 1/2, open-label, monocentric, dose-escalation study of lena...
Status
Unknown
Location
Medical University of Innsbruck, Department for Internal Medicine I
Start Date
2010-03
Trial ID
NCT01166035
Treatments Being Tested
B-cell Lymphoma is an aggressive and rare cancer of a type of immune cell (...
Status
Active Not Recruiting
Location
The University of Arizona Cancer Center - North Campus /ID# 242219
Start Date
2022-06-14
Trial ID
NCT05283720
To understand the safety and efficacy of Revlimid® Capsules 2.5 mg and 5 mg...
Status
Completed
Location
ASO KK Iizuka Hospital
Start Date
2017-05-30
Trial ID
NCT03098589
Treatments Being Tested
Double-blind randomized controlled clinical trial (RCT) of low-dose lenalid...
Status
Unknown
Location
Hospital Universitario de Getafe
Start Date
2020-10-27
Trial ID
NCT04361643
Treatments Being Tested
The purpose of this study is to compare a standard chemotherapy regimen of ...
Status
Unknown
Location
112 sites UK wide
Start Date
2010-05
Trial ID
NCT01554852
Treatments Being Tested
The main purpose of REVLIMID® DUE (Drug Use Examination) is to collect and ...
Status
Completed
Location
Hallym University Sacred Heart Hospital
Start Date
2011-03-09
Trial ID
NCT02556905
Treatments Being Tested
This study will test whether an experimental drug called Revlimid (lenalido...
Status
Completed
Location
National Cancer Institute (NCI)
Start Date
2005-04
Trial ID
NCT00109005
Treatments Being Tested
The purpose of the study is to examine efficacy and safety of epcoritamab w...
Status
Terminated
Location
UW Cancer Center at ProHealth Care
Start Date
2023-03-06
Trial ID
NCT05660967
Treatments Being Tested
The purpose of this study is to determine the maximum tolerated dose (MTD) ...
Status
Terminated
Location
University of Arizona Cancer Center, Tucson
Start Date
2017-03-05
Trial ID
NCT02954406
Treatments Being Tested